FibroBiologics, Inc. — Form D

FibroBiologics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-03. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2025-12-03
• Form: D
• Accession: 0001493152-25-025995
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $4.0M
• Amount sold: $4.0M
• Investors: 1
• Date of first sale: 2025-11-18
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-565686

Issuer

• Name: FibroBiologics, Inc.
• CIK: 0001958777
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 9350 KIRBY DRIVE SUITE 300, HOUSTON, TX, 77054
• Phone: 281-671-5150

Officers, directors & promoters (14)

Other filings by this issuer (3)

More

• CIK 1958777 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search